title: The place of myeloid growth factors in the treatment of hairy-cell leukaemia.
abstract: A patient with hairy-cell leukaemia was treated with granulocyte colony stimulating factor lenograstim (Granocyte) 300 micrograms daily by subcutaneous injections. His pre-existing neutropenia remitted and the therapy was continued for a total of 4 months. When the therapy was discontinued the neutropenia returned. There was no evidence that the growth factor itself had any disease modifying activity.
authors.affiliation: Department of Internal Medicine, Agia Olga General Hospital, Athens, Greece.
authors.forename: C
authors.initials: C
authors.lastname: Christopoulos
authors.forename: A
authors.initials: A
authors.lastname: Fortis
authors.forename: D
authors.initials: D
authors.lastname: Nikzas
authors.forename: E
authors.initials: E
authors.lastname: Anevlavis
mesh_terms: D000368:Aged; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D007279:Injections, Subcutaneous; D007943:Leukemia, Hairy Cell / Q000188:drug therapy*; D008297:Male; D009503:Neutropenia / Q000097:blood / Q000188:drug therapy; D012008:Recurrence
chemical_list: D016179:Granulocyte Colony-Stimulating Factor